Catastrophic Coverage
The final phase of Medicare Part D coverage where beneficiary cost-sharing drops to zero (2025+) or a small coinsurance after reaching the annual out-of-pocket threshold.
Catastrophic coverage is the phase of the Part D benefit structure that activates after a beneficiary's True Out-of-Pocket (TrOOP) spending reaches the annual threshold. In 2024, the TrOOP threshold is $8,000; once reached, the beneficiary pays only 5% of covered drug costs (or $4.00/$10 copays for generics/brand drugs, whichever is greater) for the remainder of the year.
Starting in 2025 under the Inflation Reduction Act, the structure changes significantly. The $2,000 beneficiary OOP cap means that once a beneficiary has spent $2,000 out-of-pocket (not counting premiums), they pay $0 for covered drugs for the rest of the year. This effectively eliminates the "catastrophic" label for most beneficiaries — the $2,000 cap is the new catastrophic threshold.
For beneficiaries on specialty drugs costing $5,000–$20,000/month (cancer therapies, immunologics, multiple sclerosis treatments), reaching the 2025 cap in the first 1–2 months of the year provides substantial financial relief for the remaining 10–11 months.
Real-World Example
A 73-year-old on a $6,500/month MS drug reached the $2,000 Part D out-of-pocket cap in early February 2025 and paid $0 for that drug for the remaining 10.5 months of the year — saving approximately $19,500 versus pre-reform cost-sharing.